Figure 1: Policy framework and future trends in the European context
The ACT-EU project is intended to accelerate clinical trials in the European Union. The elements mentioned therein should also be incorporated into German legislation. The ACT EU 2022–2026 work plan contains the planned project results and time sequences for the period from 2022 to 2026. Among others, the following project results are planned for 2023: establishing a process to support academic sponsors in conducting large multinational clinical trials, establishing a platform for dialogue between the various stakeholders in the clinical trials that should involve patients, health care professionals and contributors from academia, and promoting innovations in the methodology of decentralised clinical trials.
Figure composed of heading and title of [24] (copyright: Heads of Medicines Agencies, European Commission and European Medicines Agency) and the image “Act EU” from [25] (copyright: European Medicines Agency)